Girard Partners Ltd. Merck & Co., Inc. Transaction History

Girard Partners Ltd.

  • $1.06 Billion
  • Q1 2024

A detailed history of Girard Partners Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Girard Partners Ltd. holds 32,312 shares of MRK stock, worth $4.09 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
32,312
Previous 33,971 4.88%
Holding current value
$4.09 Million
Previous $3.7 Million 15.12%
% of portfolio
0.4%
Previous 0.38%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$113.24 - $131.95 $187,865 - $218,905
-1,659 Reduced 4.88%
32,312 $4.26 Million
Q4 2023

Feb 09, 2024
SELL
$100.18 - $109.02 $83,049 - $90,377
-829 Reduced 2.38%
33,971 $3.7 Million
Q3 2023

Nov 02, 2023
SELL
$102.95 - $114.33 $1.14 Million - $1.26 Million
-11,064 Reduced 24.12%
34,800 $3.58 Million
Q2 2023

Aug 15, 2023
BUY
$108.61 - $118.38 $2,172 - $2,367
20 Added 0.04%
45,864 $5.29 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $86,263 - $96,252
-838 Reduced 1.8%
45,844 $4.88 Million
Q4 2022

Jan 26, 2023
BUY
$87.44 - $112.11 $171,294 - $219,623
1,959 Added 4.38%
46,682 $0
Q3 2022

Oct 20, 2022
SELL
$84.53 - $94.96 $140,573 - $157,918
-1,663 Reduced 3.59%
44,723 $3.85 Million
Q2 2022

Jul 26, 2022
SELL
$83.49 - $94.64 $125,568 - $142,338
-1,504 Reduced 3.14%
46,386 $4.23 Million
Q1 2022

Apr 27, 2022
SELL
$73.51 - $82.4 $286,615 - $321,277
-3,899 Reduced 7.53%
47,890 $3.93 Million
Q4 2021

Feb 02, 2022
SELL
$72.28 - $90.54 $214,527 - $268,722
-2,968 Reduced 5.42%
51,789 $3.97 Million
Q3 2021

Nov 01, 2021
BUY
$71.68 - $78.83 $3.63 Million - $3.99 Million
50,645 Added 1231.64%
54,757 $4.11 Million
Q3 2021

Nov 01, 2021
SELL
$71.68 - $78.83 $4.09 Million - $4.5 Million
-57,076 Reduced 93.28%
4,112 $4.11 Million
Q2 2021

Aug 10, 2021
SELL
$70.31 - $77.77 $530,629 - $586,930
-7,547 Reduced 10.98%
61,188 $4.76 Million
Q1 2021

May 06, 2021
SELL
$68.86 - $81.11 $1.36 Million - $1.6 Million
-19,692 Reduced 22.27%
68,735 $5.3 Million
Q4 2020

Feb 02, 2021
BUY
$71.77 - $79.65 $193,707 - $214,975
2,699 Added 3.15%
88,427 $7.23 Million
Q3 2020

Nov 13, 2020
BUY
$73.18 - $82.95 $377,242 - $427,607
5,155 Added 6.4%
85,728 $7.11 Million
Q2 2020

Aug 10, 2020
SELL
$70.42 - $80.13 $245,906 - $279,813
-3,492 Reduced 4.15%
80,573 $6.23 Million
Q1 2020

May 05, 2020
SELL
$63.36 - $87.82 $32.8 Million - $45.5 Million
-518,169 Reduced 86.04%
84,065 $6.47 Million
Q1 2020

May 01, 2020
BUY
$63.36 - $87.82 $33.3 Million - $46.2 Million
525,807 Added 687.99%
602,234 $6.99 Million
Q4 2019

Feb 03, 2020
SELL
$77.58 - $87.54 $656,714 - $741,026
-8,465 Reduced 9.97%
76,427 $7.66 Million
Q3 2019

Nov 01, 2019
SELL
$76.08 - $82.93 $1.4 Million - $1.53 Million
-18,406 Reduced 17.82%
84,892 $7.15 Million
Q2 2019

Aug 12, 2019
BUY
$69.84 - $81.59 $189,964 - $221,924
2,720 Added 2.7%
103,298 $8.66 Million
Q1 2019

May 08, 2019
SELL
$69.58 - $79.36 $5,427 - $6,190
-78 Reduced 0.08%
100,578 $8.37 Million
Q4 2018

Feb 11, 2019
SELL
$65.24 - $75.71 $74,765 - $86,763
-1,146 Reduced 1.13%
100,656 $7.69 Million
Q3 2018

Nov 09, 2018
SELL
$57.69 - $67.84 $705,548 - $829,683
-12,230 Reduced 10.73%
101,802 $7.22 Million
Q2 2018

Aug 07, 2018
BUY
$50.83 - $59.72 $310,672 - $365,008
6,112 Added 5.66%
114,032 $6.92 Million
Q1 2018

Apr 18, 2018
BUY
$50.96 - $59.23 $245,168 - $284,955
4,811 Added 4.67%
107,920 $5.88 Million
Q4 2017

Feb 07, 2018
SELL
$51.62 - $61.64 $373,522 - $446,027
-7,236 Reduced 6.56%
103,109 $5.8 Million
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $317,228 - $341,343
5,407 Added 5.15%
110,345 $7.07 Million
Q2 2017

Aug 08, 2017
BUY
N/A
104,938
104,938 $6.73 Million

Others Institutions Holding MRK

# of Institutions
3,769
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email